Clinical Trials Browser

Approved for marketing × Pheochromocytoma × 3-Iodobenzylguanidine × Clear all

NCT01377532 2020-05-06

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

Approved for marketing

Neoplasms, Paraganglioma, Pheochromocytoma, Recurrence

NCT02961491 2019-01-30

Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma

Approved for marketing

Paraganglioma, Pheochromocytoma